Business Wire

Viridian Therapeutics Announces Pricing of Upsized Concurrent Public Offerings of 1.75% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $350 ...

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for ...
Seeking Alpha

Akamai Technologies proposes $2.6B of convertible senior notes

Akamai Technologies (AKAM) announced on Monday that it proposes to offer $1.3B in aggregate principal amount of 0% convertible senior notes due 2030 and $1.3B in aggregate principal amount of 0% ...
Business Wire

Ciena Corporation Announces Pricing of Upsized Convertible Senior Notes

HANOVER, Md.--(BUSINESS WIRE)--Ciena ® Corporation (NYSE: CIEN) (the “Company”), the global leader in high-speed connectivity, today announced that it has priced its private offering (the “Offering”) ...
Nasdaq

Celcuity Inc. Announces Concurrent Public Offerings of Convertible Senior Notes Due 2031 and Common Stock

MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...
Nasdaq

Supermicro Announces Pricing of Private Placement of $700.0 Million of New 2.25% Convertible Senior Notes Due 2028 and Pricing of Amended Convertible Senior Notes Due 2029

The New Convertible Notes will be senior, unsecured obligations of the Company and will bear interest at an annual rate of 2.25%, payable semi-annually on each January 15 and July 15, beginning on ...